More tools:Markets·Screener·Research·Chat

Benitec Biopharma Inc. Common Stock (BNTC) Financial Statements

Benitec Biopharma Inc. Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00R712L65
XNAS · usd
12.73▲ 0.04 (0.35%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales—
EV / Revenue—
EV / EBITDA
Financial Highlights
Revenue (TTM)—
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin—
Net Debt
Trading Information
Previous Close12.68
Day's Range12.51 – 13.00
52-Week Range9.75 – 16.76
Volume102.0K
Avg Volume153.3K
Share Statistics
Shares Outstanding
Employees19
ExchangeXNAS
Listed2012-07-11
Share count as of May 4, 2026
Loading Income Statement…
Key questions about Benitec Biopharma Inc. Common Stock (BNTC)
What is Benitec Biopharma Inc. Common Stock's Market Cap?
Benitec Biopharma Inc. Common Stock's Market Cap is $437.2M, based on as-reported figures from SEC (XBRL) filings.
What is Benitec Biopharma Inc. Common Stock's Enterprise Value?
Benitec Biopharma Inc. Common Stock's Enterprise Value is $252.4M, based on as-reported figures from SEC (XBRL) filings.
What is Benitec Biopharma Inc. Common Stock's EV / EBITDA?
Benitec Biopharma Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Benitec Biopharma Inc. Common Stock's Net Income (TTM)?
Benitec Biopharma Inc. Common Stock's Net Income (TTM) is -$41.5M, based on as-reported figures from SEC (XBRL) filings.
What is Benitec Biopharma Inc. Common Stock's EBITDA?
Benitec Biopharma Inc. Common Stock's EBITDA is -$46.5M, based on as-reported figures from SEC (XBRL) filings.
What is Benitec Biopharma Inc. Common Stock's Diluted EPS (TTM)?
Benitec Biopharma Inc. Common Stock's Diluted EPS (TTM) is -1.21, based on as-reported figures from SEC (XBRL) filings.
What is Benitec Biopharma Inc. Common Stock's Net Debt?
Benitec Biopharma Inc. Common Stock's Net Debt is -$184.8M, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemMar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022
Revenue:
Total revenues—
YoY growth————
Operating expenses
Research and development
General and administrative
Total operating expenses
% of revenue————
Loss from operations
% of revenue————
Other income (loss):
Foreign currency transaction gain (loss)
Interest income, net
Other expense, net
Gain on extinguishment of liabilities—
Total other income, net
Net loss
% of revenue————
Net loss attributable to common shareholders
Net loss per share: basic
Net loss per share: diluted